CLINICAL_TRIALS
trial_result
· 2022-03-21
Clinical Trial Update: Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of a fixed-dose combination of olmesartan and indapamide versus the isolated drugs for hypertension.…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brainfarma Industria Química e Farmacêutica S/A | Conditions: Hypertension, Hypertension,Essential | Phase 3 | Status: UNKNOWN